Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies


Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

Investor Contacts

Financial PR and Investor Relations

Paul McManus, Alice Woodings
& Lianne Applegarth

Walbrook PR Ltd
4 Lombard Street

Tel: +44 (0)20 7933 8780